Nature Communications Publication on Advanced AI in Biological Research by Giorgos Papanastasiou

Giorgos Papanastasiou, Lead Researcher at the Archimedes Research Unit of the Athena Research Center, Greece,and Faculty Research Fellow at Edinburgh Imaging, at the University of Edinburgh, the Queen’s Medical Research Institute, Edinburgh, UK, has co-published a Nature Communications paper on "Clinical implications of bone marrow adiposity identified by phenome-wide association and Mendelian randomization in the UK Biobank."

Prof. Papanastasiou mentions that "this project is a strong testament to the power of augmenting biological research with advanced AI and data science methods."

𝗔𝗯𝘀𝘁𝗿𝗮𝗰𝘁: Bone marrow adiposity changes in diverse diseases, but the full scope of these, and whether they are directly influenced by marrow adiposity, remains unknown. To address this, we previously measured the bone marrow fat fraction of the femoral head, total hip, femoral diaphysis, and spine of over 48,000 UK Biobank participants. Here, we first use these data for PheWAS to identify diseases associated with marrow adiposity at each site. This reveals associations with 47 incident diseases across 12 disease categories, including osteoporosis, fracture, type 2 diabetes, cardiovascular diseases, cancers, and other conditions that burden public health worldwide. Intriguingly, type 2 diabetes associates positively with spine bone marrow adiposity but negatively with marrow adiposity at femoral sites. We then establish PRSs based on bone-marrow-fat-fraction-associated SNPs and use PRS-PheWAS and Mendelian randomization to explore causal associations between marrow adiposity and disease. PRS-PheWAS reveals that genetic predisposition to increased marrow adiposity is positively associated with osteoporosis and fractures. Mendelian randomization further suggests that increased marrow adiposity at the diaphysis and total hip is causally associated with osteoporosis. Our findings substantially advance understanding of how marrow adiposity impacts human health and highlight its potential as a biomarker and/or therapeutic target for diverse human diseases.


👉 Click here to read the full paper

 
 

The project “ARCHIMEDES Unit: Research in Artificial Intelligence, Data Science and Algorithms” with code OPS 5154714 is implemented by the National Recovery and Resilience Plan “Greece 2.0” and is funded by the European Union – NextGenerationEU.

greece2.0 eu_arch_logo_en

 

Stay connected! Subscribe to our mailing list by emailing sympa@lists.athenarc.gr
with the subject "subscribe archimedes-news Firstname LastName"
(replace with your details)